ALK

FDA Approved ALK Inhibitors for ALK-Positive Non-Small Cell Lung Cancer

FDA Approved ALK Inhibitors for ALK-Positive Non-Small Cell Lung Cancer

October 30, 2022
 |  No Comments
 |  Cancer Treatment Development, Drug Discovery, Research Hotspot

Lung cancer is a major type of cancer in the world, with the highest morbidity and mortality among all malignant tumors. ALK-positive non-small cell lung cancer (ALK+ NSCLC) is a […]